• 3800+employee - Qidu Pharma Group
  • 170+ ACRES - Qidu Pharma Group
  • 4 Billion - Qidu Pharma Group
  • Short Leading time - Qidu Pharma Group
  • Stable Supply - Qidu Pharma Group
  • PACKAGING MATERIALS-Qidu Pharma Group
  • Quality Assurance - Qidu Pharma Group
  • MEDICAL DISINFECTANT-Qidu Pharma Group
  • MEDICAL CONSUMABLES-Qidu Pharma Group
  • Advanced Equipment - Qidu Pharma Group
  • APIS-Qidu Pharma Group
  • ORAL PREPARATION（CAPSULES ＆TABLE）-Qidu Pharma Group
  • page 3
  • page 4
  • page 5
  • page 6
  • page 7
  • page 8
  • page 9
  • page 10
  • page 11
  • INJECTABLE POWDER-Qidu Pharma Group
  • page 3
  • SMALL VOLUME INJECTION-Qidu Pharma Group
  • HONOR - Qidu Pharma Group
  • LARGE VOLUME INJECTION-Qidu Pharma Group
  • Blood Purification-MEDICAL CONSUMABLES-Qidu Pharma Group
  • Anti-Infective-ORAL PREPARATION（CAPSULES ＆TABLE）-Qidu Pharma Group
  • Antipyetic Analgesic-ORAL PREPARATION（CAPSULES ＆TABLE）-Qidu Pharma Group
  • Antitumor and Chemotherapy Antiemetic-ORAL PREPARATION（CAPSULES ＆TABLE）-Qidu Pharma Group
  • Cardio-Cerebrovascular-ORAL PREPARATION（CAPSULES ＆TABLE）-Qidu Pharma Group
  • Digestive System-ORAL PREPARATION（CAPSULES ＆TABLE）-Qidu Pharma Group
  • Internal Secretion-ORAL PREPARATION（CAPSULES ＆TABLE）-Qidu Pharma Group
  • Liver Disease-ORAL PREPARATION（CAPSULES ＆TABLE）-Qidu Pharma Group
  • Nutrition-ORAL PREPARATION（CAPSULES ＆TABLE）-Qidu Pharma Group
  • Fluid Balance-LARGE VOLUME INJECTION-Qidu Pharma Group
  • Anti-Infective-LARGE VOLUME INJECTION-Qidu Pharma Group
  • Parental Nutrition-LARGE VOLUME INJECTION-Qidu Pharma Group
  • Plasma Expander-LARGE VOLUME INJECTION-Qidu Pharma Group
  • Cario-Cerebrovascular-LARGE VOLUME INJECTION-Qidu Pharma Group
  • Respiratory System Injection-LARGE VOLUME INJECTION-Qidu Pharma Group
  • Antitumor and Chemotherapy Antiemetic-LARGE VOLUME INJECTION-Qidu Pharma Group
  • Liver Drug-LARGE VOLUME INJECTION-Qidu Pharma Group
  • Others-LARGE VOLUME INJECTION-Qidu Pharma Group
  • Packaging Materials
  • Medical Disinfectant
  • APIs
  • Blood Purification
  • Nutrition
  • Antipyetic Analgesic
  • Liver Disease
  • Antitumor and Chemotherapy Antiemetic
  • Digestive System
  • Anti-Infective
  • Cardio-Cerebrovascular
  • Internal Secretion
  • Injectable Powder
  • Small Volume Injection
  • Respiratory System
  • Cario-Cerebrovascular
  • Anti-Infective
  • Plasma Expander
  • Parental Nutrition
  • Fluid Balance
  • Antitumor and Chemotherapy Antiemetic
  • Liver Disease
  • Others
  • Moxifloxacin hydrochloride and sodium chloride injection has been approved for marketing
  • Qidu Pharma’s Workshop of PP Ampoule Successful Passing GMP On-site Inspection
  • Qidu Pharmaceutical Holding the Second QA Director Training Class
  • Qidu Pharma has Successfully Passed the ISO45001 and ISO50001 Management System Certification
  • Qidu Pharma won the “Most Promising Pharmaceutical Companies” among Top 100 Internationalized Pharmaceutical Companies in 2019
  • Qidu Pharma’s Launch of the First Home-made Levofloxacin Sodium Chloride Injection
  • Qidu Pharmaceutical large particle sodium bicarbonate preparation technology won the national invention patent
  • Qidu Pharmaceutical Group 2023 ten major events announced
  • The production project of large-scale injection with an annual output of 1 billion bottles of Qidu Pharmaceutical has been fully completed and put into operation
  • Seize the opportunity to expand the market to build the first brand of Pivastatin calcium tablets
  • Qidu Pharmaceutical: Practice social responsibility Highlight the responsibility of pharmaceutical enterprises
  • Qidu Pharmaceutical Qiheng ®- Compound Sodium acetate Ringer injection passed the national consistency evaluation
  • Qidu Pharmaceutical has been ranked in the top 100 of China's pharmaceutical industry for ten consecutive years
  • Professor Qiao Renzhong from Beijing University of Chemical Technology visited Qidu Pharma for inspection
  • Qidu Pharma's Compound Glucose/Electrolyte Craniocerebral Surgery Irrigation Solution becomes the first generic drug approved for market in China
  • A delegation from the Pharmaceutical Industry Chamber of Commerce of the All-China Federation of Industry and Commerce (ACFIC) conducted an inspection tour in Zibo
  • Zheng Jiaqing was honored as a National Model Worker
  • The Large-Volume Injection Production Project with an Annual Output of 1 Billion Bottles/Bags Fully Completed and Put into Operation
  • Project of 3,000-ton Large-Particle Sodium Bicarbonate API Put into Production and Passed GMP Inspection
  • Qidu Pharma Signs Strategic Cooperation Agreement with Peking University Health Science Center to Establish Joint Laboratory
  • Qidu Biotech’s Self-Developed Serum-Free Medium for Umbilical Cord Mesenchymal Stem Cells Approved for Market Launch
  • 12 Products Pass or Are Deemed to Pass Consistency Evaluation
  • Qidu Pharma’s Five Products Were Selected in China's 10th National Drug Procurement Program
  • Qidu Pharma Retains Position Among China's Top 100 Pharmaceutical Companies
  • Qidu Pharma was Recognized as National-Level Green Factory
  • Zheng Jiaqing was Elected President of Zibo Pharmaceutical Industry Chamber of Commerce
  • Provincial Key Project Site Promotion Meeting Enters Qidu Pharma
  • Qidu Biopharma was Approved to Establish "Zibo (Qidu) Cell Preparation Center and Tissue Cell Bank"
  • Director Li Jia of Shanghai Institute of Materia Medica Visits Qidu Pharma for Inspection and Exchange
  • Provincial Party Committee Standing Committee Propaganda Minister Yugang Bai came to Qidu Pharma for research
  • Academician Ma Dawei of the Chinese Academy of Sciences Shanghai Institute of Organic Sciences and his delegation visited Qidu Pharma
  • Director Wu Shifu of Medical Devices Department of Provincial Drug Administration Investigates Qidu Pharma
  • Qidu Pharma Passed Multiple Inspections by Provincial and National Drug Regulatory Authorities In May
  • Chairman Li Jun of Shandong Pharmaceutical Association Visits Qidu Pharma
  • Qidu Pharma Hosts Client Appreciation Event in Guangzhou
  • Qidu Pharma Ranked Among China’s Top 100 Pharmaceutical R&D Powerhouses
  • Peking University Health Science Center-Qidu Pharma Joint Laboratory Holds One-Year Anniversary Report Meeting
  • Three oral preparation products of Qi Du Pharma were approved for marketing on the same day
  • Qidu Pharma was awarded as the first batch of advanced intelligent factories in Shandong Province
  • Metoclopramide injection and API of Qidu Pharma were approved for marketing
  • The intelligent production project of Qidu Pharma 's annual output of 10 billion tablets of oral preparations passed the GMP on-site inspection
  • Three new products of Qidu Pharma were approved for marketing on the same day
  • China 's pharmaceutical industry main business income top 100 list released - Qidu Pharma ranked 83rd
  • Qidu Pharma’s Qigejia®—Saxagliptin and Metformin Hydrochloride Extended-Release Tablets (I) was approved for marketing
  • Qidu Pharma was selected for Shandong’s Private Enterprises Top List in 2025
  • Qidu Pharma’s Enzymatic Synthesis Process for Levocarnitine API Becomes the First Domestically Approved
  • Two Subsidiaries Obtain ISO13485 Certification for Medical Device Quality Management System
  • Qidu Pharma was awarded as nationally "Typical Practices in Promoting Rule of Law in Private Enterprises"
  • Qidu Pharma Launched 2025 "Quality Month" Activities
  • Two Key Products of Qidu Pharma were approved for marketing
  • Qidu Pharma was Selected as "National Exemplary Smart Factory"
  • Qidu Pharma Achieves Outstanding Results at the National Pharmaceutical Industry QC Group Achievements Exchange Conference
  • Qidu Pharma's Qisai®-Pioglitazone and Metformin Tablets was Approved for Marketing
  • Qidu Biopharma Successfully Obtains ISO Management System Certifications